IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study.

Gian Poalo FadiniRaffaella BuzzettiMaria Rosa FittipaldiFerruccio D'IncauAndrea Da PortoAngela GirelliLucia SimoniGiusi LastoriaAgostino Consolinull null

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

IdegLira is initiated after BOT in inadequately controlled patients to improve glycemic control, whereas in BB patients it is used to simplify the therapeutic regimen. Final results of the REX study will shed light on patients' outcomes after IdegLira treatment under routine clinical care.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
prognostic factors
glycemic control
patient reported outcomes
weight loss
quality improvement
clinical practice